Health
ESMO experts: Do not discontinue or delay cancer treatment impacting on overall survival. – Brinkwire
An ESMO interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published today in Annals of Oncology, encouraging medical oncologists worldwide not to discontinue or delay any type of anti-cancer treatment that may potentially impact on overall survival. The experts also urge to stop labelling all cancer patients as vulnerable to coronavirus infection since this may lead to inappropriate care and potential negative outcomes.
Coronavirus d…
-
Noosa News24 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General21 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General18 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business17 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?